Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo

Journal of Neurochemistry

Volumn 74, Issue 5, 2000, Pages 2213-2216

  Dehmer, Thomas ^a   Lindenau, Jörg ^a   Haid, Sibylle ^a   Dichgans, Johannes ^a   Schulz, Jörg B ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Department of Neurology ^*  (Germany)

Author keywords

Free radicals; Inflammation; Microglia; MPTP; Nitric oxide synthase; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; DOPAMINE DERIVATIVE; FREE RADICAL; NITRIC OXIDE SYNTHASE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME DEFICIENCY; INFLAMMATION; MALE; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0034006478     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0742213.x     Document Type: Article

References (24)

1. Banati R. B., Daniel S. E., and Blunt S. B. (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord. 13, 221-227.
2. Beal M. F. (1995) Aging, energy and oxidative stress in neurodegenerative disease. Ann. Neurol. 38, 357-366.
3. Bloem B. R., Irwin I., Buruma O. J. S., Haan J., Roos R. A. C., Tetrud J. W., and Langston J. W. (1990) The MPTP model: versatile contributions to the treatment. J. Neurol. Sci. 97, 273-293.
4. Bredt D. S., Glatt C. E., Hwang P. M., Fotuhi M., Dawson T. M., and Snyder S. H. (1991) Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 1, 615-624.
5. Di Monte D. A., Royland J. E., Anderson A., Castagnoli K., Castagnoli N. Jr., and Langston J. W. (1997) Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity. J. Neurochem. 69, 1771-1773.
6. Franklin K. B. J. and Paxinos G. (1996) The Mouse Brain in Stereotoxic Coordinates. Academic Press, Sydney.
7. Gonzalez-Scarano F. and Baltuch C. (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22, 219-240.
8. Good P. F., Hsu A., Werner P., Perl D. P., and Olanow C. W. (1998) Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57, 338-342.
9. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R. T., and Beal M. F. (1996) Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2, 1017-1021.
10. Heneka M. T., Löschmann P.-A., Gleichmann M., Weller M., Schulz J. B., Wüllner U., and Klockgether T. (1998) Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-α/lipopolysaccharide. J. Neurochem. 71, 88-94.
11. Hirsch E. C., Hunot S., Damier P., and Faucheux B. (1998) Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann. Neurol. 44 (Suppl.), S115-S120.
12. Hunot S., Boissiere F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., and Hirsch E. C. (1996) Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72, 355-363.
13. Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debre P., Agid Y., Dugas B., and Hirsch E. C. (1999) FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J. Neurosci. 19, 3440-3447.
14. Langston J. W., Forno L. S., Tetrud J., Reeves A. G., Kaplan J. A., and Karluk D. (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 46, 598-605.
15. Laubach V. E., Shesely E. G., Smithies O., and Sherman P. A. (1995) Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92, 10688-10692.
16. Liberatore G. T., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M., McAuliffe W. G., Dawson V. L., Dawson T. M., and Przedborski S. (1999) Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 5, 1403-1409.
17. Matthews R. T., Yang L., and Beal M. F. (1997) S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity. Exp. Neurol. 143, 282-286.
18. Moore P. K., Wallace P., Gaffen Z., Hart S. L., and Babbedge R. C. (1993) Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovacular effects. Br. J. Pharmacol. 110, 219-224.
19. Pennathur S., Jackson-Lewis V., Przedborski S., and Heinecke J. W. (1999) Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and O,O′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease. J. Biol. Chem. 274, 34621-34628.
20. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L., and Dawson T. M. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA 93, 4565-4571.
21. Schulz J. B., Matthews R. T., and Beal M. F. (1995a) Role of nitric oxide in neurodegenerative diseases. Curr. Opin. Neurol. 8, 480-486.
22. Schulz J. B., Matthews R. T., Muqit M. M. K., Browne S. E., and Beal M. F. (1995b) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64, 936-939.
23. Tatton N. A. and Kish S. J. (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77, 1037-1048.
24. Tipton K. F. and Singer T. P. (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61, 1191-1206.